AdenocarcinomaDeoxycytidineKeratin-7Neoplasms, Adnexal and Skin AppendageLymphangitisNeoplasms, Unknown PrimaryPancreatic NeoplasmsEsophagogastric JunctionKeratin-20MesotheliomaLung NeoplasmsAntimetabolites, AntineoplasticStomach NeoplasmsAntineoplastic Combined Chemotherapy ProtocolsPleural NeoplasmsTumor Markers, BiologicalEsophageal NeoplasmsPleural Effusion, MalignantImmunohistochemistryNeoplasm MetastasisBiopsy, NeedleFatal OutcomeFluorouracilTreatment OutcomeImmunoenzyme TechniquesColonic NeoplasmsCarcinoma, Pancreatic DuctalDeoxycytidine KinaseBiopsyAdenocarcinoma, MucinousTomography, X-Ray ComputedSensitivity and SpecificityCisplatinAdenocarcinoma, Bronchiolo-AlveolarCell Line, TumorAdenocarcinoma, PapillaryBarrett EsophagusCarcinoma, Non-Small-Cell LungDrug Administration ScheduleBiliary Tract NeoplasmsNeoplasm StagingCardiaInfusions, IntravenousEquilibrative Nucleoside Transporter 1Survival RateAntineoplastic AgentsDrug Resistance, NeoplasmPaclitaxelPrognosisDisease-Free SurvivalVinblastineMice, NudeTaxoidsGene Expression Regulation, NeoplasticMaximum Tolerated DoseCA-19-9 AntigenDose-Response Relationship, DrugCombined Modality TherapyDisease ProgressionXenograft Model Antitumor AssaysGallbladder NeoplasmsTumor Cells, CulturedDrug SynergismOrganoplatinum CompoundsCarcinoma, Squamous CellRibonucleoside Diphosphate ReductaseKaplan-Meier EstimateApoptosisLead RadioisotopesCarboplatinNeutropeniaCell ProliferationRadiation-Sensitizing AgentsCarcinoma, Transitional CellUrologic NeoplasmsEndometrial NeoplasmsNeoplasm InvasivenessQuinazolinesUrinary Bladder NeoplasmsNeoplasm TransplantationCarcinomaNeoplasmsAdenocarcinoma, Clear CellNeoplasms, Multiple PrimaryPrecancerous ConditionsProstatic NeoplasmsIntestinal NeoplasmsCarcinoma, Large CellCarcinoma, AdenosquamousDNA, NeoplasmNeoplasm Recurrence, LocalGuanineOvarian NeoplasmsThrombocytopeniaTime FactorsDrug Screening Assays, AntitumorRetrospective StudiesPancreaticoduodenectomyDuodenal NeoplasmsCarcinoma, Signet Ring Cell